表紙
市場調查報告書

脊髓電刺激設備:開發平台分析

Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 345363
出版日期 內容資訊 英文 152 Pages
訂單完成後即時交付
價格
Back to Top
脊髓電刺激設備:開發平台分析 Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月16日內容資訊: 英文 152 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的脊髓電刺激設備開發中產品資訊相關分析,提供您臨床實驗與產品開發的進展,彙整各階段·各市場區隔·國家 (地區) 別趨勢,企業與產品的詳細資訊,最近的產品開發及產業趨勢等資訊。

第1章 目錄

第2章 簡介

  • 脊髓電刺激設備概要

第3章 開發中的產品

  • 脊髓電刺激設備 - 各開發階段的開發中產品
  • 脊髓電刺激設備 -國家 (地區) 別的開發中產品
  • 脊髓電刺激設備 - 法規別的開發中產品
  • 脊髓電刺激設備 - 各認證時期 (估計) 的開發中產品
  • 脊髓電刺激設備 - 現在進行中的臨床實驗

第4章 脊髓電刺激設備 - 正在開發的開發中產品:各企業

  • 脊髓電刺激設備企業 - 各開發階段的開發中產品
  • 脊髓電刺激設備 - 各開發階段的開發中產品

第5章 脊髓電刺激設備企業與產品概要

  • Boston Scientific Corporation
  • Direct Spinal Therapeutics, Inc.
  • Duke University
  • Imperial College London
  • Meagan Medical Inc.
  • Medtrode Inc.
  • Medtronic plc
  • MicroTransponder Inc.
  • NeuroRecovery Technologies Inc.
  • Nuvectra Corporation
  • Saluda Medical Pty Ltd
  • St. Jude Medical, Inc.
  • Stimwave Technologies, Inc.

第6章 脊髓電刺激設備 - 最近的趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0860EPD

GlobalData's Medical Devices sector report, "Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Assessment, 2019" provides an overview of Spinal Cord Stimulators (SCS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Spinal Cord Stimulators (SCS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Spinal Cord Stimulators (SCS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Spinal Cord Stimulators (SCS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Spinal Cord Stimulators (SCS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 Spinal Cord Stimulators (SCS) Overview 10

3 Products under Development 11

  • 3.1 Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development 11
  • 3.2 Spinal Cord Stimulators (SCS) - Pipeline Products by Territory 12
  • 3.3 Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path 13
  • 3.4 Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date 14
  • 3.5 Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials 15

4 Spinal Cord Stimulators (SCS) - Pipeline Products under Development by Companies 16

  • 4.1 Spinal Cord Stimulators (SCS) Companies - Pipeline Products by Stage of Development 16
  • 4.2 Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development 17

5 Spinal Cord Stimulators (SCS) Companies and Product Overview 19

  • 5.1 Boston Scientific Corp Company Overview 19
    • 5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.2 Cerevast Therapeutics Inc Company Overview 20
    • 5.2.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.3 Direct Spinal Therapeutics, Inc. Company Overview 21
    • 5.3.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.4 Duke University Company Overview 22
    • 5.4.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.5 GTX Medical BV Company Overview 23
    • 5.5.1 GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.6 Imperial College London Company Overview 29
    • 5.6.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.7 Lawson Health Research Institute Company Overview 30
    • 5.7.1 Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.8 Meagan Medical Inc. Company Overview 31
    • 5.8.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.9 Medtronic plc Company Overview 34
    • 5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.10 Micro-Leads Inc Company Overview 37
    • 5.10.1 Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.11 MicroTransponder Inc Company Overview 39
    • 5.11.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.12 Neuronoff Inc Company Overview 40
    • 5.12.1 Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.13 Nevro Corp Company Overview 41
    • 5.13.1 Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.14 Nexstim Plc Company Overview 60
    • 5.14.1 Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.15 Nuvectra Corp Company Overview 61
    • 5.15.1 Nuvectra Corp Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.16 Saluda Medical Pty Ltd Company Overview 62
    • 5.16.1 Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.17 Soterix Medical Inc Company Overview 65
    • 5.17.1 Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.18 SpineX Company Overview 72
    • 5.18.1 SpineX Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.19 St. Jude Medical LLC Company Overview 73
    • 5.19.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.20 University of California Los Angeles Company Overview 77
    • 5.20.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.21 University of Minnesota Company Overview 79
    • 5.21.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 79
  • 5.22 Wavegate Technologies LLC Company Overview 82
    • 5.22.1 Wavegate Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 82
  • 5.23 WISE s.r.l. Company Overview 83
    • 5.23.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 83

6 Spinal Cord Stimulators (SCS)- Recent Developments 84

  • 6.1 Nov 25, 2019: Stimwave Technologies halts commercialization of product line in Australia 84
  • 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 84
  • 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 86
  • 6.4 Nov 12, 2019: Nuvectra continuing to support current patients with the Algovita Implant as company voluntarily files for chapter 11 88
  • 6.5 Nov 08, 2019: University of Wisconsin Madison: Injectable, flexible electrode could replace rigid nerve-stimulating implants 88

7 Appendix 149

  • 7.1 Methodology 149
  • 7.2 About GlobalData 152
  • 7.3 Contact Us 152
  • 7.4 Disclaimer 152

List of Tables

  • Table 1: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
  • Table 2: Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
  • Table 3: Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
  • Table 4: Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
  • Table 5: Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials
  • Table 6: Spinal Cord Stimulators (SCS) Companies - Pipeline Products by Stage of Development
  • Table 7: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
  • Table 8: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Next Generation SCS System - Product Status
  • Table 10: Next Generation SCS System - Product Description
  • Table 11: Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Transdermal Electrical Neurostimulation Device - Product Status
  • Table 13: Transdermal Electrical Neurostimulation Device - Product Description
  • Table 14: Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Iowa-Patch System - Product Status
  • Table 16: Iowa-Patch System - Product Description
  • Table 17: Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Spinal Cord Stimulator - Product Status
  • Table 19: Spinal Cord Stimulator - Product Description
  • Table 20: GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: External Transcutaneous Spinal Cord Stimulation Device - Product Status
  • Table 22: External Transcutaneous Spinal Cord Stimulation Device - Product Description
  • Table 23: Targeted Epidural Spinal Stimulation Device - Product Status
  • Table 24: Targeted Epidural Spinal Stimulation Device - Product Description
  • Table 25: GTX Medical BV - Ongoing Clinical Trials Overview
  • Table 26: External Transcutaneous Spinal Cord Stimulation Device - Activity Dependent Rehabilitation Via Transcutaneous Electrical Spinal Stimulation to Restore Upper Extremity Functions in Spinal Cord Injury
  • Table 27: Targeted Epidural Spinal Stimulation Device - Efficacy of Spinal Epidural Electrical Stimulation (EES) in Combination with Robot-assisted Neurorehabilitation in Patients with Spinal Cord Injury (STIMO)
  • Table 28: Targeted Epidural Spinal Stimulation Device - Enabling Forelimb Function with Agonist Drug and Epidural Stimulation in SCI
  • Table 29: Targeted Epidural Spinal Stimulation Device - Targeting Improvements in Bowel Function and Quality of Life Using Epidural Stimulation and Training After Severe Spinal Cord Injury
  • Table 30: Targeted Epidural Spinal Stimulation Device - Task and Physiological Specific Stimulation for Recovery of Autonomic Function, Voluntary Movement, and Standing Using Epidural Stimulation and Training After Severe Spinal Cord Injury
  • Table 31: Targeted Epidural Spinal Stimulation Device - Task-specific Epidural Stimulation and Training for Recovery of Stepping, Standing and Voluntary Movement Following Severe Spinal Cord Injury
  • Table 32: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Wireless Intraspinal Microstimulation System - Product Status
  • Table 34: Wireless Intraspinal Microstimulation System - Product Description
  • Table 35: Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Spinal Implant - Parkinson's Disease - Product Status
  • Table 37: Spinal Implant - Parkinson's Disease - Product Description
  • Table 38: Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: DISCSS IFC System - Product Status
  • Table 40: DISCSS IFC System - Product Description
  • Table 41: Meagan Medical Inc. - Ongoing Clinical Trials Overview
  • Table 42: DISCSS IFC System - Pilot Study to Examine the Feasibility of the DISCSS
  • Table 43: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: MRI Surgical Lead - Product Status
  • Table 45: MRI Surgical Lead - Product Description
  • Table 46: Next Generation Intellis - Product Status
  • Table 47: Next Generation Intellis - Product Description
  • Table 48: PrimeADVANCED - Heart Failure - Product Status
  • Table 49: PrimeADVANCED - Heart Failure - Product Description
  • Table 50: Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: HD64 Implantable Therapy System - Product Status
  • Table 52: HD64 Implantable Therapy System - Product Description
  • Table 53: Intelligent Spinal Interface - Product Status
  • Table 54: Intelligent Spinal Interface - Product Description
  • Table 55: MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: SAINT System - Chronic Pain - Product Status
  • Table 57: SAINT System - Chronic Pain - Product Description
  • Table 58: Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Injectrode - Product Status
  • Table 60: Injectrode - Product Description

List of Figures

  • Figure 1: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
  • Figure 2: Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
  • Figure 3: Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
  • Figure 4: Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
  • Figure 5: Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials
Back to Top